Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… SODIUM IODIDE, I-123 CAPSULE; ORAL 100uCi SODIUM IODIDE I 123 GE HEALTHCARE | 071909 SODIUM IODIDE, I-123 CAPSULE; ORAL 100uCi SODIUM IODIDE I 123 MALLINCKRODT | 071910 SODIUM IODIDE, I-123 CAPSULE; ORAL 200uCi SODIUM IODIDE I 123 MALLINCKRODT | 018671 SODIUM IODIDE, I-123 CAPSULE; ORAL 100uCi SODIUM IODIDE I 123 SYNCOR PHARMS | 018671 SODIUM IODIDE, I-123 CAPSULE; ORAL 200uCi SODIUM IODIDE I 123 SYNCOR PHARMS | 017630 SODIUM IODIDE, I-123 SOLUTION; ORAL 2mCi/ML SODIUM IODIDE I 123 GE HEALTHCARE | 010929 SODIUM IODIDE, I-131 CAPSULE; ORAL 1-130mCi IODOTOPE BRACCO | 016517 SODIUM IODIDE, I-131 CAPSULE; ORAL 0.8-100mCi SODIUM IODIDE I 131 MALLINCKRODT | 016517 SODIUM IODIDE, I-131 CAPSULE; ORAL 15-100uCi SODIUM IODIDE I 131 MALLINCKRODT | 021305 SODIUM IODIDE, I-131 SOLUTION; ORAL 1-250mCi/0.25ML SODIUM IODIDE I 131, KIT DRAXIMAGE | 021305 SODIUM IODIDE, I-131 SOLUTION; ORAL 1-500mCi/0.5ML SODIUM IODIDE I 131, KIT DRAXIMAGE | 016515 SODIUM IODIDE, I-131 SOLUTION; ORAL 3.5-150mCi/VIAL SODIUM IODIDE I 131 MALLINCKRODT | Sodium Iodide I 131 Capsules, Draximage, New or Modified Indication | Sodium Iodide I 123 (Sodium Iodide I-123 Capsules), GE Healthcare, Labeling Revision | Sodium Iodide I 131 Capsule USP, DRAXIMAGE, Labeling Revision | Sodium Iodide I 131 Capsule USP, Draxis Specialty Pharma, Labeling Revision | Sodium Iodide I 131 Capsule, Draximage, Labeling Revision | Sodium Iodide I 131 Capsules and Solution, Draximage, Labeling Revision | Sodium Iodide I-123 Capsules, Syncor Pharmaceuticals, Inc., Labeling Revision | Hicon (sodium iodide I-131) Oral Solution, Jubilant DraxImage Inc., Labeling Revision | Hicon (sodium iodide i-131) Oral Solution, Kendle International Inc., Manufacturing Change or Addition ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com